Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unraveling the protein kinase C/NDRG1 signaling network in breast cancer.
Saponaro C, Damato M, Stanca E, Aboulouard S, Zito FA, De Summa S, Traversa D, Schirosi L, Bravaccini S, Pirini F, Fonzi E, Tebaldi M, Puccetti M, Gaballo A, Pantalone L, Ronci M, Magnani L, Sergi D, Tinelli A, Tacconi S, Siculella L, Giudetti AM, Fournier I, Salzet M, Trerotola M, Vergara D. Saponaro C, et al. Among authors: pirini f. Cell Biosci. 2024 Dec 30;14(1):156. doi: 10.1186/s13578-024-01336-z. Cell Biosci. 2024. PMID: 39736699 Free PMC article.
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer.
Cortesi M, Bravaccini S, Ravaioli S, Petracci E, Angeli D, Tumedei MM, Balzi W, Pirini F, Zanoni M, Possanzini P, Rocca A, Palleschi M, Ulivi P, Martinelli G, Maltoni R. Cortesi M, et al. Among authors: pirini f. Cancers (Basel). 2024 Nov 6;16(22):3752. doi: 10.3390/cancers16223752. Cancers (Basel). 2024. PMID: 39594707 Free PMC article.
Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival.
Rivera-Peña B, Folawiyo O, Turaga N, Rodríguez-Benítez RJ, Felici ME, Aponte-Ortiz JA, Pirini F, Rodríguez-Torres S, Vázquez R, López R, Sidransky D, Guerrero-Preston R, Báez A. Rivera-Peña B, et al. Among authors: pirini f. Oncol Lett. 2024 Jan 8;27(3):89. doi: 10.3892/ol.2024.14223. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38268779 Free PMC article.
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival.
Tumedei MM, Piccinini F, Azzali I, Pirini F, Bravaccini S, De Matteis S, Agostinelli C, Castellani G, Zanoni M, Cortesi M, Vergani B, Leone BE, Righi S, Gazzola A, Casadei B, Gentilini D, Calzari L, Limarzi F, Sabattini E, Pession A, Tazzari M, Bertuzzi C. Tumedei MM, et al. Among authors: pirini f. Int J Mol Sci. 2023 Jun 8;24(12):9909. doi: 10.3390/ijms24129909. Int J Mol Sci. 2023. PMID: 37373066 Free PMC article.
Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.
Zampiga V, Cangini I, Bandini E, Azzali I, Ravegnani M, Ravaioli A, Mancini S, Tebaldi M, Tedaldi G, Pirini F, Veneroni L, Frassineti GL, Falcini F, Danesi R, Calistri D, Arcangeli V. Zampiga V, et al. Among authors: pirini f. Cancers (Basel). 2023 Apr 3;15(7):2132. doi: 10.3390/cancers15072132. Cancers (Basel). 2023. PMID: 37046793 Free PMC article.
Why the complications of COVID-19 patients differ in elderly and young cancer patients.
Bravaccini S, Nicolini F, Zanoni M, Gaimari A, Cerchione C, Maltoni R, Pirini F, Mazzotti L, Cortesi M, Ravaioli S, Tumedei MM, Mazza M. Bravaccini S, et al. Among authors: pirini f. Transl Oncol. 2022 Dec;26:101541. doi: 10.1016/j.tranon.2022.101541. Epub 2022 Sep 12. Transl Oncol. 2022. PMID: 36119944 Free PMC article.
Androgen receptor in breast cancer: The "5W" questions.
Ravaioli S, Maltoni R, Pasculli B, Parrella P, Giudetti AM, Vergara D, Tumedei MM, Pirini F, Bravaccini S. Ravaioli S, et al. Among authors: pirini f. Front Endocrinol (Lausanne). 2022 Aug 30;13:977331. doi: 10.3389/fendo.2022.977331. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36111296 Free PMC article. Review.
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer.
Cortesi M, Zanoni M, Maltoni R, Ravaioli S, Tumedei MM, Pirini F, Bravaccini S. Cortesi M, et al. Among authors: pirini f. Expert Opin Ther Targets. 2022 Jul;26(7):593-602. doi: 10.1080/14728222.2022.2113513. Epub 2022 Aug 19. Expert Opin Ther Targets. 2022. PMID: 35962580
33 results